CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK (CISS)

Registry ID

201411-2177

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

OTTAWA HOSPITAL RESEARCH INSTITUTE

Start date

2015-04-28

Last update

2014-12-19

Conditions

• SEPTIC SHOCK

Related clinical trials

• BETA-BLOCKER THERAPY VERSUS STANDARD CARE IN PATIENTS WITH SEPTIC SHOCK: A PILOT RANDOMIZED CONTROLLED TRIAL UTILIZING PREDICTIVE ENRICHMENT WITH POINT-OF-CARE ULTRASOUND
• UMBILICAL MESENCHYMAL STROMAL CELLS AS CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK (UC-CISS II): A MULTI-CENTER, DOUBLE-BLIND, PHASE II RANDOMIZED CONTROLLED TRIAL
• PRAGMATIC PEDIATRIC TRIAL OF BALANCED VERSUS NORMAL SALINE FLUIDS IN SEPSIS (PROMPT BOLUS)
• HEPARIN ANTICOAGULATION TO IMPROVE OUTCOMES IN SEPTIC SHOCK: THE HALO INTERNATIONAL PHASE II RCT
• TREATMENT OF SEPTIC SHOCK BY INHIBITING AUTODIGESTION AND PRESERVING GUT INTEGRITY WITH ENTERIC LB1148 (SSAIL STUDY)

View on source registry